Abstract 19030: Growth Arrest-Specific 5, a Novel Regulator of Adipose Tissue Browning

Dilbar Mehdi,Shiyou Chen
DOI: https://doi.org/10.1161/circ.148.suppl_1.19030
IF: 37.8
2023-11-07
Circulation
Abstract:Background: Obesity is a global epidemic with significant health risks, including type 2 diabetes and cardiovascular diseases. Increasing white adipose tissue (WAT) browning has shown metabolic benefits in both animal models and humans. Long non-coding RNAs (lncRNAs), have been implicated in various diseases, including metabolic disorders. Growth arrest-specific 5 (GAS5), a tumor suppressor lncRNA decreased in type 2 diabetic patients, has been found to be involved in adipocyte differentiation, however, the role of GAS5 in WAT browning has not yet been established. We hypothesized that in the presence of an adipose tissue browning stimuli, GAS5 promotes WAT browning Methods: In vitro approaches through knocking down or overexpressing GAS5 were used to determine its role in regulating thermogenic genes and thermogenesis. To test the role of GAS5 in adipose tissue browning in vivo , adenovirus AAV8 expressing GAS5 was administered specifically in epidydimal adipose tissues followed by the treatment of browning stimuli CL-316,243. Results: Knockdown of GAS5 increased Smad3 phosphorylation, which was blocked by Smad3 inhibitor, SIS3. Conversely, overexpression of GAS5 inhibited Smad3 phosphorylation. On the other hand, Smad3 overexpression blocked the stimulatory effects of GAS5 on the expression of thermogenic genes PGC-1α and UCP1. Moreover, overexpression of GAS5 inhibited, while knockdown of GAS5 enhanced, Smad3 nuclear translocation and tis binding to PGC-1α promoter. In vivo experiments with GAS5 overexpression in epididymal adipose tissues revealed that GAS5 promotes CL-316,243-induced WAT browning in mice. Conclusions: Our study demonstrates that GAS5 promotes WAT browning by suppressing Smad3 signaling, which in turn increases thermogenesis via stimulating PGC-1α and UCP1 expression. These findings establish GAS5 as a novel regulator of WAT browning with potential implications for mitigating obesity and associated metabolic disorders.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?